Antibody-mediated rejection: treatment alternatives and outcomes
- 1 January 2009
- journal article
- review article
- Published by Elsevier in Transplantation Reviews
- Vol. 23 (1) , 34-46
- https://doi.org/10.1016/j.trre.2008.08.004
Abstract
No abstract availableKeywords
This publication has 121 references indexed in Scilit:
- 14th International HLA and Immunogenetics Workshop: Report on the Prospective Chronic Rejection ProjectTissue Antigens, 2007
- Banff ’05 Meeting Report: Differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy (’CAN’)American Journal of Transplantation, 2007
- Characterization of rejection episodes in patients following positive crossmatch and ABO-incompatible live donor renal transplantationTransplant International, 2006
- Current approaches to treatment of antibody‐mediated rejectionPediatric Transplantation, 2005
- Mycophenolate Mofetil Substitution for Cyclosporine A in Renal Transplant Recipients with Chronic Progressive Allograft Dysfunction: The ???Creeping Creatinine??? Study1Transplantation, 2005
- Transplanting patients with a positive donor‐specific crossmatch: A single center's perspectivePediatric Transplantation, 2004
- Antibody-directed therapy: Past, present, and futureJournal of Allergy and Clinical Immunology, 2001
- Hapten-Induced Primary and Memory Humoral Responses Are Inhibited by the Infusion of Anti-CD20 Monoclonal Antibody (IDEC-C2B8, Rituximab)Clinical Immunology, 2001
- Significant post‐transplant hypogammaglobulinemia in six heart transplant recipients: an emerging clinical phenomenon?Transplant Infectious Disease, 2000
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999